跳至主要内容
临床试验/NL-OMON24231
NL-OMON24231已完成不适用

Dose response trial of IV immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.

Erasmus MC 's Gravendijkwal 230 Rotterdam3000 CANetherlands0 个研究点目标入组 17 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
17

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Diagnosis of CIDP or acute-onset CIDP made by a consultant neurologist, fulfilling the European Federation of Neurological Societies/Peripheral Nerve Society (EFNS/PNS) clinical diagnostic criteria;
  • 2. Age 18 years or older;

排除标准

  • 1. Known IgA deficiency or known allergic reaction to IVIg.
  • 2. Hand grip strength measured by the Martin Vigorimeter equal or more than the median value (kPa) for an age and sex matched healthy control;

研究者

发起方
Erasmus MC 's Gravendijkwal 230 Rotterdam3000 CANetherlands

相似试验